Insulin and oral hypoglycaemics.
The management of diabetes involves an individualised diet and exercise programme, patient education about all aspects of diabetes care (including blood or urine tests for glucose) and attention to other risk factors for macrovascular disease such as smoking, hypertension and hypercholesterolaemia. Recent advances in these aspects of diabetes and better understanding of the differences between insulin dependent and noninsulin dependent diabetes have had a major influence on the way insulin and oral hypoglycaemics are now used.
D000042:Absorption; D000328:Adult; D000818:Animals; D002417:Cattle; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000378:metabolism / Q000627:therapeutic use*; D007328:Insulin / Q000378:metabolism / Q000627:therapeutic use*; D007700:Kinetics; D013552:Swine
D007004:Hypoglycemic Agents; D007328:Insulin